Molecular subtypes of pancreatic cancer

Collisson, Eric A., Bailey, Peter, Chang, David K., Biankin, Andrew V.·2019·Nature Reviews Gastroenterology & Hepatology

DOI 10.1038/s41575-019-0109-y

Cited by (895)

Items 201–300 of 895

Pancreatic stellate cell‐derived exosomal tRF‐19‐PNR8YPJZ promotes proliferation and mobility of pancreatic cancer through AXIN2
Wenpeng Cao, Shisi Dai, Wanyuan Ruan, Tingting Long, Zhirui Zeng, Shan Lei · 2023 · Journal of Cellular and Molecular Medicine
Proteomics-Driven Biomarkers in Pancreatic Cancer
Luís Ramalhete, Emanuel Vigia, Ruben Araújo, Hugo P. Marques · 2023 · Proteomes
Single-cell RNA-seq reveals characteristics in tumor microenvironment of PDAC with MSI-H following neoadjuvant chemotherapy with anti-PD-1 therapy
Kai Chen, Yongsu Ma, Xinxin Liu, Xiejian Zhong, Long Di, Xiaodong Tian, Lei Zheng, Yinmo Yang · 2023 · Cancer Letters
Benefits and Pitfalls of a Glycosylation Inhibitor Tunicamycin in the Therapeutic Implication of Cancers
Snigdha Banerjee, Affan A. Ansari, Sunil P. Upadhyay, Daniel J. Mettman, Jamie R. Hibdon, Mohiuddin Quadir, Pratyusha Ghosh, Anjali Kambhampati, Sushanta K. Banerjee · 2024 · Cells
Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction
Kazuhide Matsumoto, Nao Fujimori, Kazuya Ichihara, Ayumu Takeno, Masatoshi Murakami, Akihisa Ohno, Shotaro Kakehashi, Katsuhito Teramatsu, Keijiro Ueda, Kohei Nakata et al. · 2024 · Journal of Gastroenterology
Circular RNA CDR1as promotes tumor progression by regulating miR-432-5p/E2F3 axis in pancreatic cancer
Xingcheng Xiong, Jiarui Feng, Xiao Yi Yang, Hanjun Li, Qiao Shi, Jing Tao, Jian Hua Chang · 2021 · Cancer Cell International
A Novel AMPK Inhibitor Sensitizes Pancreatic Cancer Cells to Ferroptosis Induction
Carolin Schneider, Jorina Hilbert, Franziska Génevaux, Stefanie Höfer, Lukas Krauß, Felix Schicktanz, Constanza Tapia Contreras, Shaishavi Jansari, Aristeidis Papargyriou, Thorsten Richter et al. · 2024 · Advanced Science
Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles
Hassan A. Ali, Joanna M. Karasinska, James Thomas Topham, Danisha Johal, Steve E. Kalloger, Andrew Metcalfe, Cassia Warren, A. Miyagi, Lan Valerie Tao, Maya Kevorkova et al. · 2024 · Cancer & Metabolism
Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy
Sharavan Ramachandran, Sanjay Srivastava · 2020 · Molecular Therapy — Oncolytics
Multimodal Therapies against Pancreatic Ductal Adenocarcinoma: A Review on Synergistic Approaches toward Ultimate Nanomedicine Treatments
Marzia Conte, Valentina Cauda · 2022 · Advanced Therapeutics
Clinical utility of endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling of pancreatic cancer
Nozomi Okuno, Kazuo Hara, Nobumasa Mizuno, Shin Haba, Takamichi Kuwahara, Yasuhiro Kuraishi, Daiki Fumihara, Takafumi Yanaidani · 2023 · Clinical Endoscopy
Functional and Clinical Proteomic Exploration of Pancreatic Cancer
Peiwu Huang, Weina Gao, Changying Fu, Ruijun Tian · 2023 · Molecular & Cellular Proteomics
Post‐operative mortality and recurrence patterns in pancreatic cancer according to <i>KRAS</i> mutation and <scp>CDKN2A</scp> , p53, and <scp>SMAD4</scp> expression
Masugi, Yohei, Takamatsu, Manabu, Tanaka, Mariko, Hara, Kensuke, Inoue, Yosuke, Hamada, Tsuyoshi, Suzuki, Tatsunori, Arita, Junichi, Hirose, Yuki, Kawaguchi, Yoshikuni et al. · 2023 · The Journal of Pathology: Clinical Research
Pancreatic cancer detection and characterization—state of the art cross-sectional imaging and imaging data analysis
Georgios A. Kaissis, Rickmer Braren · 2019 · Translational Gastroenterology and Hepatology
Precision Targeting Strategies in Pancreatic Cancer: The Role of Tumor Microenvironment
Nikolaos Vitorakis, Antonios N. Gargalionis, Kostas A. Papavassiliou, Christos Adamopoulos, Athanasios G. Papavassiliou · 2024 · Cancers
Metabolic Profiling of Early and Late Recurrent Pancreatic Ductal Adenocarcinoma Using Patient-Derived Organoid Cultures
Lukas M. Braun, Simon Lagies, Rhena F. U. Klar, Saskia Hussung, Ralph Fritsch, Bernd Kammerer, Uwe A. Wittel · 2020 · Cancers
Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC
Katharina Lankes, Zonera Hassan, Josefina Doffo, Christian Schneeweis, Svenja Lier, Rupert Öllinger, Roland Rad, Oliver Holger Krämer, Ulrich Bernd Keller, Dieter Saur et al. · 2020 · Molecular Oncology
Drivers of Gene Expression Dysregulation in Pancreatic Cancer
Swati Venkat, Abdulrahman A. Alahmari, Michael E. Feigin · 2021 · Trends in cancer
Truncated O-Glycan-Bearing MUC16 Enhances Pancreatic Cancer Cells Aggressiveness via α4β1 Integrin Complexes and FAK Signaling
Christabelle Rajesh, Satish Sagar, Rathinavel Ashokkumar, Divya T. Chemparathy, Xianlu L. Peng, Jen Jen Yeh, Michael Anthony Hollingsworth, Prakash Radhakrishnan · 2022 · International Journal of Molecular Sciences
Obesity-Associated Cancers: Evidence from Studies in Mouse Models
Ho Lee · 2022 · Cells
Metabolism‐Based Molecular Subtyping Endows Effective Ketogenic Therapy in p53‐Mutant Colon Cancer
Meng Tang, Hui Xu, Hongyan Huang, Hao Kuang, Chenxi Wang, Qinqin Li, Xin Zhang, Yi‐Zhong Ge, Mengmeng Song, Xi Zhang et al. · 2022 · Advanced Science
Genome-wide CRISPR screens define determinants of epithelial-mesenchymal transition mediated immune evasion by pancreatic cancer cells
Yuanzhuo Gu, Zhengkui Zhang, Marcel G M Camps, FERRY A. OSSENDORP, Ruud H. M. Wijdeven, Peter ten Dijke · 2023 · Science Advances
Phloretin-induced STAT3 inhibition suppresses pancreatic cancer growth and progression via enhancing Nrf2 activity
Qingqing Ruan, Chunmei Wen, Guihua Jin, Ziwei Yuan, Xuejia Yang, Zhikai Wen, Gang Huang, Guogang Li, Jie Deng, Yongheng Bai · 2023 · Phytomedicine
CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes
Yanfen Zheng, Xingyang Li, Shuang Deng, Hongzhe Zhao, Ying Ye, Shaoping Zhang, Xudong Huang, Ruihong Bai, Lisha Zhuang, Quanbo Zhou et al. · 2023 · Nature Communications
Cytotoxicity of combinations of the pan-KRAS SOS1 inhibitor BAY-293 against pancreatic cancer cell lines
Plangger, Adelina, Rath, Barbara, Stickler, Sandra, Hochmair, Maximilian, Lang, Clemens, Weigl, Lukas, Funovics, Martin, Hamilton, Gerhard · 2022 · Discover Oncology
Pharmacological inhibition of SREBP1 suppresses pancreatic cancer growth via inducing GPX4-mediated ferroptosis
Ruiqi Cao, Zhengyuan Feng, Jiantao Mo, Jiaoxing Wu, Jie Li, Wei Li, Zheng Wang, Qingyong Ma, Zheng Wu, Cancan Zhou · 2024 · Cellular Signalling
Poly( ADP ‐ribose) polymerase inhibition in pancreatic cancer
Hans Martin Singh, Peter J. Bailey, Daniel Hübschmann, Anne Katrin Berger, John P. Neoptolemos, Dirk Jäger, Jens Thomas Siveke, Christoph Springfeld · 2020 · Genes Chromosomes and Cancer
Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma
Ujjwal Mukund Mahajan, Ahmed Alnatsha, Qi Li, Bettina Oehrle, Frank Ulrich Weiß, Matthias Sendler, Marius Distler, Waldemar H. Uhl, Tim Fahlbusch, Elisabetta Goni et al. · 2021 · Cells
Gα15 in early onset of pancreatic ductal adenocarcinoma
Giulio Innamorati, Thomas Martin Wilkie, Giorgio Malpeli, Salvatore Paiella, Silvia Grasso, Borislav Chavdarov Rusev, Biagio Eugenio Leone, Maria Teresa Valenti, Luca Dalle Carbonare, Samuele Cheri et al. · 2021 · Scientific Reports
The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer
Stephan B. Dreyer, Sarah Rae, Kirsty Bisset, Rosanna Upstill‐Goddard, Georgios Gemenetzis, Amber L. Johns, Australian Pancreatic Cancer Genome Initiative, Euan J. Dickson, Anubhav Mittal, Anthony James Gill et al. · 2021 · Annals of Surgery
HOXD9‑induced SCNN1A upregulation promotes pancreatic cancer cell proliferation, migration and predicts prognosis by regulating epithelial‑mesenchymal transformation
Jin‐Hai Chang, Xuguang Hu, Jinniang Nan, Xianghua Zhang, Xintian Jin · 2021 · Molecular Medicine Reports
Computational approaches leveraging integrated connections of multi-omic data toward clinical applications
Habibe Cansu Demirel, Muslum Kaan Arici, Nurcan Tunçbağ · 2021 · Molecular Omics
LncRNA MACC1-AS1 induces gemcitabine resistance in pancreatic cancer cells through suppressing ferroptosis
Jiyun Zhu, Zehao Yu, Xuguang Wang, Jinghui Zhang, Yi Chen, Kaibo Chen, Bin Zhang, Jianhong Sun, Jianshuai Jiang, Siming Zheng · 2024 · Cell Death Discovery
Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication
Yu-Hsuan Hung, Ming-Chuan Hsu, Li-Tzong Chen, W. Hung, Mei-Ren Pan · 2019 · Journal of Clinical Medicine
The impact of metastatic sites in advanced pancreatic adenocarcinoma, systematic review and meta-analysis of prospective randomized studies
Pedro Luiz Serrano Usón, Fernanda Davila Sampaio Tolentino, Vanessa Montes Santos, Edna Terezinha Rother, Fernando Cotait Maluf · 2020 · PLoS ONE
Phenotypic heterogeneity and tumor immune microenvironment directed therapeutic strategies in pancreatic ductal adenocarcinoma
Remya P. G. Ramesh, Hadida Yasmin, Pretty Ponnachan, Basel K. al-Ramadi, Uday Kishore, Ann Mary Joseph · 2025 · Frontiers in Immunology
Treatment of KRAS-Mutated Pancreatic Cancer: New Hope for the Patients?
Kamila Krupa, Marta Magdalena Fudalej, Emilia Włoszek, Hanna Miski, Anna Maria Badowska-Kozakiewicz, Dominika Mękal, Michał Piotr Budzik, Aleksandra Izabela Czerw, Andrzej Deptała · 2025 · Cancers
[18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma
Felix N. Harder, Friederike Jungmann, Georgios A. Kaissis, Fabian Karl Lohöfer, Sebastian Ziegelmayer, Daniel Havel, Michael Quante, Maximilian Reichert, Roland Michael Schmid, İhsan Ekin Demir et al. · 2021 · EJNMMI Research
An analysis of classical multidimensional scaling with applications to clustering
Anna V. Little, Yuying Xie, Qiang Sun · 2022 · Information and Inference A Journal of the IMA
Deep structure integrative representation of multi-omics data for cancer subtyping
Bo Yang, Yan Ling Yang, Xueping Su · 2022 · Bioinformatics
Development and validation of an MRI-radiomics nomogram for the prognosis of pancreatic ductal adenocarcinoma
Xinsen Xu, Jiaqi Qu, Yijue Zhang, Xiaohua Qian, Tao Chen, Yingbin Liu · 2023 · Frontiers in Oncology
Molecular Subtyping and Survival Analysis of Osteosarcoma Reveals Prognostic Biomarkers and Key Canonical Pathways
Siddesh Southekal, Sushil Kumar Shakyawar, Prachi Bajpai, Amr Elkholy, Upender Manne, Nitish K. Mishra, Chittibabu Guda · 2023 · Cancers
Wnt-deficient and hypoxic environment orchestrates squamous reprogramming of human pancreatic ductal adenocarcinoma
Hiroki Tamagawa, Masayuki Fujii, Kazuhiro Togasaki, Takashi Seino, Shintaro Kawasaki, Ai Takano, Kohta Toshimitsu, Sirirat Takahashi, Yuki Ohta, Mami Matano et al. · 2024 · Nature Cell Biology
Bcl3 Couples Cancer Stem Cell Enrichment With Pancreatic Cancer Molecular Subtypes
Jiaoyu Ai, Sonja M. Wörmann, Kıvanç Görgülü, Mireia Vallespinós, Sladjana Zagorac, Sonia Alcalá, Nan Wu, Derya Kabacaoğlu, Alexandra Berninger, Diego Navarro et al. · 2021 · Gastroenterology
Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma–A Review of the Literature
Jakub Szymon Wnuk, Joanna Katarzyna Strzelczyk, Iwona Gisterek · 2023 · International Journal of Molecular Sciences
Valosin-Containing Protein Stabilizes Mutant p53 to Promote Pancreatic Cancer Growth
Jieqiong Wang, Yajie Chen, Canhua Huang, Qian Hao, Shelya X. Zeng, Sara Omari, Yu Zhang, Xiang Yu Zhou, Hua Lu · 2021 · Cancer Research
An Integrated Deep Network for Cancer Survival Prediction Using Omics Data
Hamid Reza Hassanzadeh, May Dongmei Wang · 2021 · Frontiers in Big Data
Deconstructing Pancreatic Cancer Using Next Generation-Omic Technologies–From Discovery to Knowledge-Guided Platforms for Better Patient Management
Daniel Schreyer, John P. Neoptolemos, Simon T. Barry, Peter Bailey · 2022 · Frontiers in Cell and Developmental Biology
Insight of pancreatic cancer: recommendations for improving its therapeutic efficacy in the next decade
Zhihang Xu, Wenquan Wang, Wenhui Lou, Liang Liu · 2022 · Journal of Pancreatology
Loss of microRNA ‐21 leads to profound stromal remodeling and short survival in K‐Ras ‐driven mouse models of pancreatic cancer
Josh Schipper, Jennifer J. Westerhuis, Ian Beddows, Zach B. Madaj, David J. Monsma, Galen H. Hostetter, Matti Kiupel, Jose Ramon Conejo-Garcia, Lorenzo F. Sempere · 2020 · International Journal of Cancer
Efficient, high-performance semantic segmentation using multi-scale feature extraction
Moritz A. Knolle, Georgios A. Kaissis, Friederike Jungmann, Sebastian Ziegelmayer, Daniel Sasse, Marcus R. Makowski, Daniel Rueckert, Rickmer Braren · 2021 · PLoS ONE
The potential of dopamine receptor D2 (DRD2) as a therapeutic target for tackling pancreatic cancer
Rowa Bakadlag, Pouria Jandaghi, Jörg D. Hoheisel, Yasser Riazalhosseini · 2019 · Expert Opinion on Therapeutic Targets
Hallmarks of pancreatic cancer: spotlight on TAM receptors
Núria Vázquez-Bellón, Neus Martínez‐Bosch, Pablo Garcı́a de Frutos, Pilar Navarro · 2024 · EBioMedicine
Emerging insights into lineage plasticity in pancreatic cancer initiation, progression, and therapy resistance
Xintong Zhang, Yaru Du, Axel Behrens, Linxiang Lan · 2025 · Developmental Cell
Identification of prognosis-related molecular subgroups based on DNA methylation in pancreatic cancer
Xiaoli Yin, Lingming Kong, Peng Liu · 2021 · Clinical Epigenetics
IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinoma
Rong Wei, Guoye Qi, Zixin Zeng, Ningning Shen, Ziyue Wang, Honghong Shen, Lifang Gao, Chen Song, Wenxia Ma, Chen Wang · 2021 · Cancer Cell International
The biology of pancreatic cancer morphology
Oliver Gene McDonald · 2021 · Pathology
ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer
Harun Öztürk, Harun Cingoz, Turan Tufan, Jiekun Yang, Sara J. Adair, Krishna Seshu Tummala, Cem Kuscu, Meric Kinali, Gamze Cömertpay, Sarbajeet Nagdas et al. · 2022 · Developmental Cell
The molecular landscape of pancreatic ductal adenocarcinoma
Lavanya Sivapalan, Hemant Mahendrakumar Kocher, Helen Ross‐Adams, Claude Chelala · 2022 · Pancreatology
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma
Andrea Mafficini, Michele Simbolo, Tatsuhiro Shibata, Seung‐Mo Hong, Antonio Pea, Lodewijk A.A. Brosens, Liang Cheng C, Davide Antonello, Concetta Sciammarella, Cinzia Cantù et al. · 2022 · Modern Pathology
Laser Capture Microdissection: A Gear for Pancreatic Cancer Research
Bhavana Hemantha Rao, Pavel Souček, Viktor Hlaváč · 2022 · International Journal of Molecular Sciences
AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer
Christian Schneeweis, Sandra Diersch, Zonera Hassan, Lukas Krauß, Carolin Schneider, Daniele Lucarelli, Chiara Falcomatà, Katja Steiger, Rupert Öllinger, Oliver Holger Krämer et al. · 2022 · Cellular and Molecular Life Sciences
Single-cell omics: a new perspective for early detection of pancreatic cancer?
Qi Wang, Berina Šabanović, Azhar Awada, Chiara Reina, Alexandra Aicher, Jiajia Tang, Christopher Heeschen · 2023 · European Journal of Cancer
Synergistic antitumor efficacy of gemcitabine and cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via Sp1-SAT1-polyamine metabolism pathway
Wan-Hui Wei, Yuanyuan Lu, Qian Hu, Jinwen Yin, Youwei Wang, Heng Zhang, Qiu Zhao, Lan Liu · 2023 · Cellular Oncology
Single-cell mapping identifies MSI+ cells as a common origin for diverse subtypes of pancreatic cancer
Nirakar Rajbhandari, Michael Hamilton, Cynthia M Quintero, Lesley Paige Ferguson, Raymond G. Fox, Christian M. Schürch, Jun Wang, Mari Nakamura, Nikki K. Lytle, Matthew L. McDermott et al. · 2023 · Cancer Cell
RN0D, a galactoglucan from Panax notoginseng flower induces cancer cell death via PINK1/Parkin mitophagy
Meng Ji, Long Sun, Minghui Zhang, Yulin Liu, Zhenqing Zhang, Peipei Wang · 2024 · Carbohydrate Polymers
A Novel Method for Cancer Subtyping and Risk Prediction Using Consensus Factor Analysis
Duc Tran, Hung Nguyen, Uyen Q. Le, George N. Bebis, Hung Nguyen Luu, Tin Nguyen · 2020 · Frontiers in Oncology
Prognosis of pancreatic head cancer with different patterns of lymph node metastasis
Seung Ki Min, Yunghun You, Dong Wook Choi, In Woong Han, Sang Hyun Shin, So Kyung Yoon, Ji Hye Jung, So Jeong Yoon, Jin Seok Heo · 2022 · Journal of Hepato-Biliary-Pancreatic Sciences
Nutritional Glutamine-Modified Iron-Delivery System with Enhanced Endocytosis for Ferroptosis Therapy of Pancreatic Tumors.
Yang Chen, Wenzhe Xu, Hao Jin, Meng-Si Zhang, Shu-Wei Liu, Yi Liu, Hao Zhang · 2024 · ACS Nano
Establishing 3D organoid models from patient-derived conditionally reprogrammed cells to bridge preclinical and clinical insights in pancreatic cancer
Jin Su Kim, Chan Hee Park, Eun‐Young Kim, Hee Seung Lee, Jin-Young Lee, Jeehoon Kim, Eun Hee Kam, Sanghee Nam, Moon Jae Chung, Jeong Youp Park et al. · 2025 · Molecular Cancer
Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma
Xiu Hu, Wei Chen · 2021 · World Journal of Clinical Cases
Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines
Angela Ragone, Alessia Salzillo, Annamaria Spina, Silvio Naviglio, Luigi Sapio · 2022 · Frontiers in Pharmacology
Role of Epigenetics in Pancreatic Ductal Adenocarcinoma
Somnath Pandey, Vineet Kumar Gupta, Shweta Lavania · 2023 · Epigenomics
Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice
Takuo Yamai, Kenji Ikezawa, Naotoshi Sugimoto, Makiko Urabe, Yugo Kai, Ryoji Takada, Tasuku Nakabori, Hiroyuki Uehara, Takahisa Kawamura, Kei Kunimasa et al. · 2023 · Cancers
Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs
Audrey Lumeau, Nicolas Béry, Audrey Francès, Marion Gayral, Guillaume Labrousse, Cyril Ribeyre, Charlene Lopez, Adèle Nevot, Abdessamad El Kaoutari, Naima Hanoun et al. · 2024 · Cancer Research
Placental growth factor promotes neural invasion and predicts disease prognosis in resectable pancreatic cancer
Andreas Göhrig, Georg Hilfenhaus, Friederike Rosseck, Martina Welzel, Benjamin Moser, Gianluca Barbone, Catarina Alisa Kunze, Johannes Rein, Gregor Wilken, Michael Böhmig et al. · 2024 · Journal of Experimental & Clinical Cancer Research
Interaction between MED12 and ΔNp63 activates basal identity in pancreatic ductal adenocarcinoma
Diogo Maia-Silva, Patrick J. Cunniff, Allison C. Schier, Damianos S. Skopelitis, Marygrace C. Trousdell, Philip Moresco, Yuan Gao, Vahag Kechejian, Xue‐Yan He, Yunus Sahin et al. · 2024 · Nature Genetics
Is There a Trojan Horse to Aggressive Pancreatic Cancer Biology? A Review of the Trypsin-PAR2 Axis to Proliferation, Early Invasion, and Metastasis
Kjetil Søreide, Marcus T. T. Roalsø, Jan Rune Aunan · 2020 · Journal of Pancreatic Cancer
Proteostasis Dysregulation in Pancreatic Cancer
Leena Arpalahti, Caj Haglund, Carina I. Holmberg · 2020 · Advances in experimental medicine and biology
Clinical characteristics and blood/serum bound prognostic biomarkers in advanced pancreatic cancer treated with gemcitabine and nab-paclitaxel
Hakon Blomstrand, Henrik Gréen, Mats G. Fredrikson, Emma Gränsmark, Bergþór Björnsson, Nils O. Elander · 2020 · BMC Cancer
Autophagy Regulatory Genes MET and RIPK2 Play a Prognostic Role in Pancreatic Ductal Adenocarcinoma: A Bioinformatic Analysis Based on GEO and TCGA
Xingyu Li, Zhiqiang Li, Hongwei Zhu, Xiao Yu · 2020 · BioMed Research International
Intron retention is a robust marker of intertumoral heterogeneity in pancreatic ductal adenocarcinoma
Daniel J. Tan, Mithun Mitra, Alec M. Chiu, Hilary A. Coller · 2020 · npj Genomic Medicine
Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction Model
Yang Gao, Enchong Zhang, Xiang Fei, Lingming Kong, Peng Liu, Xiaodong Tan · 2021 · Frontiers in Cell and Developmental Biology
Discovery of GOT1 Inhibitors from a Marine-Derived Aspergillus terreus That Act against Pancreatic Ductal Adenocarcinoma
Shan Yan, Changxing Qi, Wei Song, Qianqian Xu, Lianghu Gu, Weiguang Sun, Yonghui Zhang · 2021 · Marine Drugs
ROR1 and ROR2 expression in pancreatic cancer
Dongli Liu, George Sharbeen, Phoebe A. Phillips, Australian Pancreatic Cancer Genome Initiative, Amber L. Johns, Anthony James Gill, Lorraine A. Chantrill, Paul Timpson, Angela S. Y. Chou, Marina Pajic et al. · 2021 · BMC Cancer
Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies
Miguel Angel Ortega, Leonel Pekarek, Oscar Fraile‐Μartinez, Cielo García Montero, Miguel A. Sáez, Ángel Asúnsolo, Miguel Ángel Álvarez-Mon, Jorge Monserrat, Lidia Ruiz-Llorente, Natalio García‐Honduvilla et al. · 2022 · Current Oncology
GABRP is a potential prognostic biomarker and correlated with immune infiltration and tumor microenvironment in pancreatic cancer
Yihui Yang, Liwen Ren, Sha Li, Xiangjin Zheng, Jinyi Liu, Li Wan, Weiqi Fu, Jinhua Wang, Guanhua Du · 2022 · Translational Cancer Research
The Role of Feedback Loops in Targeted Therapy for Pancreatic Cancer
Weigang Gu, Hongzhang Shen, Lu Xie, Xiaofeng Zhang, Jianfeng Yang · 2022 · Frontiers in Oncology
Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment
Αναστάσιος Γκουντάκος, Filippo Maria Martelli, Nicola Silvestris, Michele Bevere, Mario De Bellis, Laura Alaimo, Elena Sapuppo, Francesca Masetto, Aldo Mombello, Michele Simbolo et al. · 2023 · Cancers
Proteasome-dependent senescent tumor cells mediate immunosuppression through CCL20 secretion and M2 polarization in pancreatic ductal adenocarcinoma
Mengwei Wu, Jiashu Han, Hao Wu, Ziwen Liu · 2023 · Frontiers in Immunology
Machine learning identifies SLC6A14 as a novel biomarker promoting the proliferation and metastasis of pancreatic cancer via Wnt/β-catenin signaling
Cunshu Dang, Quan Bian, Fengbiao Wang, Han Wang, Zhipeng Liang · 2024 · Scientific Reports
Role of UFMylation in tumorigenesis and cancer immunotherapy
Lijuan Ding, Xin Mei Jiang, Te Li, Shudong Wang · 2024 · Frontiers in Immunology
Efficacy of 1-Kestose Supplementation in Patients with Pancreatic Ductal Adenocarcinoma: A Randomized Controlled Pilot Study
Kazunori Nakaoka, Eizaburo Ohno, Kento Kuramitsu, Teiji Kuzuya, Kohei Funasaka, Takumi Tochio, Tadashi Fujii, Hideaki Takahashi, Nobuhiro Kondo, Ryoji Miyahara et al. · 2024 · Nutrients
Fatty acid synthase (FASN) inhibition cooperates with BH3 mimetic drugs to overcome resistance to mitochondrial apoptosis in pancreatic cancer
Travis Vander Steen, Ingrid C. Espinoza, Cristina Duran, Guillem Casadevall, Eila Serrano‐Hervás, Elisabet Cuyàs, Sara Verdura, George W. Kemble, Scott H. Kaufmann, Robert R. McWilliams et al. · 2025 · Neoplasia
Pancreatic stromal Gremlin 1 expression during pancreatic tumorigenesis
Joy M. Davis, Binglu Cheng, Madeline Drake, Qiang Yu, Baibing Yang, Jing Li, Chunhui Liu, Mamoun Younes, Xiurong Zhao, Jennifer M. Bailey et al. · 2020 · Genes & Diseases
An unbiased high‐throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer
Chun‐Hao Pan, Yuka Otsuka, BanuPriya Sridharan, Melissa Woo, Cindy V. Leiton, Sruthi Babu, Mariana Torrente Gonçalves, Ryan R. Kawalerski, Ji Dong K. Bai, David Kuang-Fu Chang et al. · 2020 · Molecular Oncology
Regulation of metabolic reprogramming by tumor suppressor genes in pancreatic cancer
Mengqi Liu, Wensheng Liu, Yi Qin, Xiaowu Xu, Xianjun Yu, Qifeng Zhuo, Shunrong Ji · 2020 · Experimental Hematology and Oncology
The germline/somatic DNA damage repair gene mutations modulate the therapeutic response in Chinese patients with advanced pancreatic ductal adenocarcinoma
Lin Shui, Xiaofen Li, Yang Peng, Jiangfang Tian, Shuangshuang Li, Du He, Ang Li, Bole Tian, Li Mao, Heli Gao et al. · 2021 · Journal of Translational Medicine
Rationale for MYC imaging and targeting in pancreatic cancer
Günter Schneider, Matthias Wirth, Ulrich Bernd Keller, Dieter Saur · 2021 · EJNMMI Research
IGFBP2 Drives Regulatory T Cell Differentiation through STAT3/IDO Signaling Pathway in Pancreatic Cancer
Longhao Sun, Yang Zhang, Tiantian Yang, Junhang Chen, Xuebin Zhang, Xiaoyu Liang · 2022 · Journal of Personalized Medicine